MedBen Rx Blog
Fraker, Fargus Featured Speakers at Healthcare Innovation Conference
MedBen Vice Presidents Caroline Fraker and Brian Fargus were among the featured speakers at the Sherrill-Morgan 7th Annual Healthcare Innovation Conference on Thursday, October 1. In her presentation, Senior Vice President Fraker discussed the potential problems of...
MedBen Saving Solutions Counter Affordability Concerns
A National Alliance of Healthcare Purchaser Coalitions survey asked employers what they thought were the greatest threats to coverage affordability. Their responses… and how MedBen counters these concerns with proven saving solutions: Drug prices are a threat to...
“Wasteful Drugs” Cost Employers $6 Billion Annually
Employers could save billion of dollars every year by avoiding “wasteful drugs,” according to BenefitsPro. Guidelines from Pacific Business Group on Health and and researchers from Johns Hopkins University identified 49 high-price medications with less costly...
Most Expensive Drugs in the U.S.
Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at...
MedBen Rx Advocate Continues to Save
Three-quarters of MedBen clients have switched to MedBen Rx Advocate for their pharmacy benefits. “And when they do, they are saving money,” said Brian Fargus, MedBen’s VP of Sales & Marketing. In 2019 MedBen Rx clients saved 12.0% average cost per script, and an...
Comparing Traditional and Pass-Thru PBM Contracts
As an agent or a plan administrator, it is important to understand how PBM contracts compare – “not just in terms of the numbers calculated for things like discounts and rebates, but also in terms of how they function and align (or fail to align) with your client’s...
The MedBen Rx Advocate Model: Pass-through Transparency, No Margin Manipulation
A recent Benefits Pro article highlights two pharmacy benefits management (PBM) business models: traditional and pass-through. MedBen Rx Advocate begins with the pass-through approach but takes it one step further by eliminating margin manipulation. The traditional...
MedBen Rx Saves
Three-quarters of MedBen clients use MedBen Rx prescription programs and are seeing the benefits first-hand. By utilizing our forward-thinking pharmacy solutions, these groups realized an average savings of 14.8% per employee per year, compared to those using other...
MedBen Conducts 14th Annual Municipality Roundtable Webinar
From 2015 to 2019, MedBen’s municipality block saw just a 2.7% trend on total claim costs. At the 14th Annual Municipality Roundtable Webinar on April 30, Vice President of Sales & Marketing Brian Fargus shared that municipality medical costs trended at 3.4%...
No Change In Drug Refill Policy Recommended
With the novel coronavirus COVID-19 a constant topic in the news nowadays, many consumers are stocking up on various drugs. MedBen is recommending no change to the current prescription drug refill guidelines for our clients and here’s why: Most wholesalers have a good...
MedBen Rx Advocate Pricing Transparency Eliminates PBM Manipulation
MedBen Rx Advocate offers clients true transparency by removing the ability for pharmacy benefits managers to manipulate drug pricing. By using fee-based pricing, we avoid the margin markups that PBM “middlemen” use to inflate their profits. The Hill reports that...
Rx Pricing Transparency Critical to Lower Drug Costs, Employers Say
According to the National Alliance of Healthcare Purchaser Coalitions, more than 60% of employers say drug spending is unsustainable for their business, and they’re now demanding drug pricing transparency – something MedBen Rx Advocate already delivers. With MedBen Rx...